Exciting news on the epinephrine front as Orexo's nasal epinephrine device makes its way through clinical trials. This trial shows that OX640 works even better when the patient has allergic rhinitis. #foodallergies
snacksafely.com/2025/01/nasa...
snacksafely.com/2025/01/nasa...
Nasal Emergency Epinephrine Alternative Shows Positive Topline Data in Clinical Study
OX640 is a nasal rescue medication with powder-based epinephrine for the treatment of allergic reactions.
snacksafely.com
January 16, 2025 at 3:20 PM
Exciting news on the epinephrine front as Orexo's nasal epinephrine device makes its way through clinical trials. This trial shows that OX640 works even better when the patient has allergic rhinitis. #foodallergies
snacksafely.com/2025/01/nasa...
snacksafely.com/2025/01/nasa...
The #FDA accepted an investigational new drug application for the #epinephrine #intranasal #powder #OX640 for treating #anaphylaxis, according to a press release from #Orexo. www.healio.com/news/...
September 19, 2026 at 11:00 AM
The #FDA accepted an investigational new drug application for the #epinephrine #intranasal #powder #OX640 for treating #anaphylaxis, according to a press release from #Orexo. www.healio.com/news/...
Orexo Unveils Promising Clinical Findings for OX640 at EAACI Congress 2025 in Glasgow#Sweden#Orexo#AmorphOX#Uppsala#OX640
Orexo Unveils Promising Clinical Findings for OX640 at EAACI Congress 2025 in Glasgow
Orexo announces its participation at the 2025 EAACI Congress, showcasing groundbreaking findings for OX640, a nasal treatment for severe allergic reactions.
third-news.com
June 2, 2025 at 1:42 PM
Orexo to Showcase Breakthrough Clinical Data for OX640 at the Upcoming EAACI Congress in Glasgow#Sweden#Orexo#Uppsala#OX640#EAACI
Orexo to Showcase Breakthrough Clinical Data for OX640 at the Upcoming EAACI Congress in Glasgow
Orexo AB announces its participation at the EAACI Congress, presenting promising data for OX640, a nasal rescue treatment for severe allergies.
third-news.com
June 2, 2025 at 1:40 PM
Orexo's OX640 Clinical Study: Breakthrough Nasal Medication for Allergic Reactions#Sweden#Orexo#AmorphOX#Uppsala#OX640
Orexo's OX640 Clinical Study: Breakthrough Nasal Medication for Allergic Reactions
Orexo has announced positive results from a clinical study of OX640, a nasal medication aimed at treating allergic reactions, promising rapid effectiveness.
third-news.com
January 10, 2025 at 1:38 PM
Orexo's OX640 Clinical Study Shows Promise for Allergy Treatments with Rapid Effects#Sweden#Orexo#AmorphOX#Uppsala#OX640
Orexo's OX640 Clinical Study Shows Promise for Allergy Treatments with Rapid Effects
Orexo's recent clinical trial for its nasal medication OX640 has shown encouraging results, indicating rapid absorption and effectiveness for allergy treatments.
third-news.com
January 10, 2025 at 1:37 PM
Orexo initiates new study of OX640 in participants with allergic rhinitis
www.viv-media.com/infozx-34890...
www.viv-media.com/infozx-34890...
Orexo initiates new study of OX640 in participants with allergic rhinitis
www.viv-media.com
October 26, 2024 at 2:16 PM
Orexo initiates new study of OX640 in participants with allergic rhinitis
www.viv-media.com/infozx-34890...
www.viv-media.com/infozx-34890...
